R. Chee, Samir N. Patel, Karyn Jonas, M. Gupta, M. Chiang, R. Chan, J. Campbell
{"title":"早产儿视网膜病变远程医疗的发展趋势","authors":"R. Chee, Samir N. Patel, Karyn Jonas, M. Gupta, M. Chiang, R. Chan, J. Campbell","doi":"10.15234/VPA.V1I1.399","DOIUrl":null,"url":null,"abstract":"Retinopathy of Prematurity (ROP) is a vasoproliferative disease of the retina in premature infants that can progress to blindness. Clinical ROP management standards have been established by seminal studies such as the Cryotherapy for ROP (CRYO-ROP) and Early Treatment for ROP (ET-ROP) trials, and have significantly decreased the incidence of poor visual outcomes in ROP. However, ROP continues to be a leading cause of childhood blindness worldwide.","PeriodicalId":53032,"journal":{"name":"Vision PanAmerica","volume":"80 1","pages":"7-11"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Current Trends in Telemedicine for Retinopathy of Prematurity\",\"authors\":\"R. Chee, Samir N. Patel, Karyn Jonas, M. Gupta, M. Chiang, R. Chan, J. Campbell\",\"doi\":\"10.15234/VPA.V1I1.399\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Retinopathy of Prematurity (ROP) is a vasoproliferative disease of the retina in premature infants that can progress to blindness. Clinical ROP management standards have been established by seminal studies such as the Cryotherapy for ROP (CRYO-ROP) and Early Treatment for ROP (ET-ROP) trials, and have significantly decreased the incidence of poor visual outcomes in ROP. However, ROP continues to be a leading cause of childhood blindness worldwide.\",\"PeriodicalId\":53032,\"journal\":{\"name\":\"Vision PanAmerica\",\"volume\":\"80 1\",\"pages\":\"7-11\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vision PanAmerica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15234/VPA.V1I1.399\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vision PanAmerica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15234/VPA.V1I1.399","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Current Trends in Telemedicine for Retinopathy of Prematurity
Retinopathy of Prematurity (ROP) is a vasoproliferative disease of the retina in premature infants that can progress to blindness. Clinical ROP management standards have been established by seminal studies such as the Cryotherapy for ROP (CRYO-ROP) and Early Treatment for ROP (ET-ROP) trials, and have significantly decreased the incidence of poor visual outcomes in ROP. However, ROP continues to be a leading cause of childhood blindness worldwide.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
